We are live on ! Find out more
MGP

M&G plc Portfolio holdings

AUM $20.1B
1-Year Est. Return 16.62%
This Fund
S&P 500
This Quarter Est. Return
-0.47%
1 Year Est. Return
+16.62%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.4B
AUM Growth
-$107M
Cap. Flow
+$1.01M
Cap. Flow %
0.01%
Top 10 Hldgs %
31.82%
Holding
423
New
51
Increased
131
Reduced
125
Closed
43

Sector Composition

Rank Sector Weight
1 Technology 20.57%
2 Healthcare 16.38%
3 Consumer Discretionary 15.42%
4 Financials 11.36%
5 Communication Services 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSLR icon
301
First Solar
FSLR
$26.9B
$1.14M 0.01%
5,775
BBIO icon
302
BridgeBio Pharma
BBIO
$16.5B
$1.11M 0.01%
15,041
CVS icon
303
CVS Health
CVS
$122B
$1.11M 0.01%
15,356
+2,782
+22% +$214K
IONS icon
304
Ionis Pharmaceuticals
IONS
$9.4B
$1.08M 0.01%
14,423
ECL icon
305
Ecolab
ECL
$79.9B
$1.07M 0.01%
4,033
-117
-3% -$33K
SBUX icon
306
Starbucks
SBUX
$120B
$1.03M 0.01%
11,445
-11,790
-51% -$1.12M
TEAM icon
307
Atlassian
TEAM
$37.8B
$1.02M 0.01%
+14,986
New +$1.48M
AMD icon
308
Advanced Micro Devices
AMD
$789B
$985K 0.01%
4,854
+2,005
+70% +$428K
TGT icon
309
Target
TGT
$68B
$977K 0.01%
8,077
WELL icon
310
Welltower
WELL
$171B
$948K ﹤0.01%
4,786
+34
+0.7% +$6.72K
MESO
311
Mesoblast
MESO
$2.07B
$887K ﹤0.01%
+59,100
New +$984K
KVYO icon
312
Klaviyo
KVYO
$4.73B
$814K ﹤0.01%
42,818
ROP icon
313
Roper Technologies
ROP
$39.8B
$724K ﹤0.01%
+2,046
New +$755K
AXON
314
Axon Enterprise
AXON
$46.4B
$702K ﹤0.01%
1,651
-4,909
-75% -$2.55M
ECHO
315
EchoStar
ECHO
$26.2B
$658K ﹤0.01%
+5,624
New +$645K
ALV icon
316
Autoliv
ALV
$9B
$550K ﹤0.01%
5,236
IRM icon
317
Iron Mountain
IRM
$36.1B
$530K ﹤0.01%
5,193
+230
+5% +$22.9K
O icon
318
Realty Income
O
$59.1B
$516K ﹤0.01%
8,457
+4,265
+102% +$267K
PGNY icon
319
Progyny
PGNY
$2.2B
$477K ﹤0.01%
28,082
-848
-3% -$18.2K
VICI icon
320
VICI Properties
VICI
$29.4B
$416K ﹤0.01%
15,403
+682
+5% +$19.5K
VLTO icon
321
Veralto
VLTO
$24B
$402K ﹤0.01%
4,566
+366
+9% +$34.8K
XYL icon
322
Xylem
XYL
$28.1B
$387K ﹤0.01%
3,229
+275
+9% +$36.1K
RUN icon
323
Sunrun
RUN
$2.46B
$387K ﹤0.01%
27,655
YUMC icon
324
Yum China
YUMC
$16.3B
$383K ﹤0.01%
7,826
EW icon
325
Edwards Lifesciences
EW
$51.7B
$373K ﹤0.01%
4,661

Similar funds

M&G plc's Q1 2026 Portfolio in Review

As of Q1 2026, M&G plc held 423 positions worth $19.4B, down 0.55% from $19.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

M&G plc's Q1 2026 filing shows 51 new, 131 increased, 125 reduced and 43 closed positions. Its largest new stake was AstraZeneca: 4,204,199 shares worth $817M. The largest sale was Lam Research, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • M&G plc's largest Q1 2026 buy was AstraZeneca: 4,204,199 shares worth $817M.
  • M&G plc added most to Microsoft in Q1 2026, an estimated $183M increase.
  • M&G plc's biggest Q1 2026 reduction was Lam Research, cutting an estimated $190M.
  • M&G plc fully exited Crown Castle in Q1 2026, selling an estimated $34M.
  • M&G plc's ten largest holdings make up 32% of its $19.4B portfolio in Q1 2026.
  • M&G plc opened 51 new positions and closed 43 in Q1 2026.
  • M&G plc's portfolio value fell 0.55% quarter-over-quarter to $19.4B.

Based on M&G plc's 13F filing for Q1 2026, filed 13 May 2026.